InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by JOHNSON KENNETH ERLAND. Insider active across 2 companies, notably Xeris Pharmaceuticals INC. In total, 6 reports have been logged. Activity tracked since 3 January 2022. The latest transaction was disclosed on 3 January 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
75,000 shares0Common StockSEC:0001867096-22-000010
75,000 shares0Common StockSEC:0001867096-22-000010:0
11,250 sharesCommon StockSEC:0000899243-21-039319:0
11,250 sharesCommon StockSEC:0000899243-21-039246:0
11,250 sharesCommon StockSEC:0000899243-21-039319
11,250 sharesCommon StockSEC:0000899243-21-039246
6 of 6 declarations
About JOHNSON KENNETH ERLAND
Kenneth Erland Johnson is a director at Xeris Pharmaceuticals INC and Xeris Biopharma Holdings, Inc.
